Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
06 08 2020
06 08 2020
Historique:
received:
26
02
2020
accepted:
21
07
2020
entrez:
9
8
2020
pubmed:
9
8
2020
medline:
18
12
2020
Statut:
epublish
Résumé
The incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing in some regions. Nevertheless, the epidemiology of this disease has not been extensively investigated in southern Europe. We conducted a retrospective cohort study of patients diagnosed with primary oropharyngeal cancer from 1991 to 2016. Cancer tissues underwent histopathological evaluation, DNA quality control, HPV-DNA detection and p16
Identifiants
pubmed: 32764593
doi: 10.1038/s41598-020-70118-7
pii: 10.1038/s41598-020-70118-7
pmc: PMC7411067
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13219Références
IARC. IARC Monographs on the evaluation of carcinogenic risks to humans. Monograph89, 223–276 (2007).
De Martel, C., Plummer, M., Vignat, J. & Franceschi, S. Worldwide burden of cancer attributable to HPV by site country and HPV type. Int. J. Cancer141(4), 664–670 (2017).
pubmed: 28369882
pmcid: 5520228
Chaturvedi, A. K. et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol.29, 4294–4301 (2011).
pubmed: 21969503
pmcid: 3221528
Nasman, A. et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?. Int. J. Cancer125, 362–366 (2009).
pubmed: 19330833
Hannisdal, K., Schjølberg, A., De Angelis, P. M., Boysen, M. & Clausen, O. P. Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway. Acta Otolaryngol.130, 293–299 (2010).
pubmed: 19680990
Garnaes, E. et al. A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000–2010: The largest registry-based study to date. Int. J. Cancer136(9), 2196–2203 (2015).
pubmed: 25283302
Rietbergen, M. M. et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int. J. Cancer132, 1565–1571 (2013).
pubmed: 22949073
Gillison, M. L., Chaturvedi, A. K., Anderson, W. F. & Fakhry, C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J. Clin. Oncol.33(29), 3235–3242 (2015).
pubmed: 26351338
pmcid: 4979086
Taberna, M. et al. Human papillomavirus-related oropharyngeal cancer. . Ann. Oncol.00, 1–13 (2017).
Castellsagué, X. et al. HPV Involvement in head and neck cancers: Comprehensive assessment of biomarkers in 3680 patients. J. Natl. Cancer Inst.108(6), djv03 (2016).
Rodrigo, J. P. et al. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990–2009). Int. J. Cancer134(2), 487–492 (2014).
pubmed: 23824638
Cerezo, L. et al. OPC related to human papilloma virus: Incidence and prognosis in Madrid,. Clin. Transl. Oncol.16(3), 301–306 (2014).
pubmed: 23828503
Mena, M. et al. Double positivity for HPV-DNA/p16
pubmed: 29496041
Del Mistro, A. et al. Age-independent increasing prevalence of human papillomavirus-driven oropharyngeal carcinomas in North-East Italy. Sci. Rep.10(1), 9320 (2020).
pubmed: 32518378
pmcid: 7283341
Westra, W. H. Detection of human papillomavirus (HPV) in clinical samples: Evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral. Oncol.50(9), 771–779 (2014).
pubmed: 24932529
pmcid: 4318232
Leeper, T. J. Prediction: Tidy, Type-Safe 'prediction()' Methods. R package version 0.2.0 (2017).
Alemany, L. et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int. J. Cancer136(1), 98–107 (2015).
pubmed: 24817381
Clèries, R. et al. Monitoring the decreasing trend of testicular cancer mortality in Spain during 2005–2019 through a Bayesian approach. Cancer Epidemiol.34(3), 244–256 (2010).
pubmed: 20381445
Gelman, A., & Su, Y. Arm: Data Analysis Using Regression and Multilevel/Hierarchical Models. R package version 1.9–3 (2016).
Botta, L. et al. Angelis R, et al on behalf of the RARECAREnet Working group. Bayesian estimates of the incidence of rare cancers in Europe. Cancer Epidemiol.54, 95–100 (2018).
pubmed: 29684802
de Souza, D. L., Pérez, M. M. & Curado, M. P. Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control. Cancer Epidemiol.35(6), 510–514 (2011).
pubmed: 21470934
Ferlay, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer144(8), 1941–1953 (2019).
pubmed: 30350310
Gillison, M. L. et al. Human papillomavirus and diseases of the upper airway: Head and neck cancer and respiratory papillomatosis. Vaccine30(Suppl 5), F34–F54 (2012).
pubmed: 23199965
Chaturvedi, A. K., D’Souza, G., Gillison, M. L. & Katki, H. A. Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. Population. Oral Oncol60, 61–7 (2016).
pubmed: 27531874
Rettig, E. M. et al. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of human papillomavirus is attenuated among older patients: Analysis of the national cancer database. Oral. Oncol.83, 147–153 (2018).
pubmed: 30098771
pmcid: 6500732
Windon, M. J. et al. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults. Cancer124(14), 2993–2999 (2018).
pubmed: 29710393
pmcid: 6033632
Combes, J. D., Chen, A. A. & Franceschi, S. Prevalence of human papillomavirus in cancer of the oropharynx by gender. Cancer Epidemiol. Biomark. Prev.23(12), 2954–2958 (2014).
Cleries, R. et al. Time trends of cancer incidence and mortality in Catalonia during 1993–2007. Clin. Transl. Oncol.16(1), 18–28 (2014).
pubmed: 23740137
Giuliano, A. R. et al. EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int. J. Cancer136(12), 2752–2760 (2015).
pubmed: 25043222
Heck, J. E. et al. Sexual behaviours and the risk of head and neck cancers: A pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int. J. Epidemiol.39(1), 166–181 (2010).
pubmed: 20022926
Castellsagué, X. et al. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study. J. Med. Virol.84(6), 947–956 (2012).
pubmed: 22499018
Fakhry, C., Andersen, K. K., Christensen, J., Agrawal, N. & Eisele, D. W. The impact of tonsillectomy upon the risk of oropharyngeal carcinoma diagnosis and prognosis in the danish cancer registry. Cancer Prev. Res. (Phila.)8(7), 583–589 (2015).
Chaturvedi, A. et al. Tonsillectomy and incidence of oropharyngeal cancers. Cancer Epidemiol. Biomark. Prev.25(6), 944–950 (2016).
Schache, A. G. et al. HPV-related oropharynx cancer in the United Kingdom: An evolution in the understanding of disease etiology. Cancer Res.76(22), 6598–6606 (2016).
pubmed: 27569214
Haeggblom, L., Ramqvist, T., Tommasino, M., Dalianis, T. & Näsman, A. Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years. Papillomavirus Res4, 1–11 (2017).
pubmed: 29179862
pmcid: 5883233
Grønhøj Larsen, C. et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: A systematic review. Br. J. Cancer110(6), 1587–1594 (2014).
pubmed: 24518594
pmcid: 3960616
Perrone, F. et al. Isolating p16 positive/HPV negative oropharyngeal cancer: An effort worth making. Am. J. Surg. Pathol.2011(35), 774–777 (2011).
Jordan, R. C. et al. Validation of methods for OPC HPV status determination in US cooperative group trials. Am. J. Surg. Pathol.36(7), 945–954 (2012).
pubmed: 22743284
pmcid: 6362985
Coordes, A. et al. Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status. Eur. Arch. Otorhinolaryngol.273(8), 2157–2169 (2016).
pubmed: 26227616
Rietbergen, M. M. et al. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas. Int. J. Cancer134(10), 2366–2372 (2014).
pubmed: 24249631
Galceran, J., Ameijide, A., Alemany, L., Carulla, M., Marcos, R., Vilardell, L., et al. Incidence and mortality of neoplasias related to Human papillomavirus in Catalonia. In XXXV Scientific Meeting of the Spanish Society of Epidemiology (SEE), Oral Presentation, (2017).